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Selecting B cells and plasma cells to memory
 
Thomas Dörner and Andreas Radbruch
 
Humoral immunity appears to be based on immunological memory provided by 
memory plasma cells, which secrete protective antibodies, and memory B cells, 
which react to antigen challenge by differentiating into plasma cells. How 
these differentiation pathways relate to each other, how cells are selected 
into these memory populations, and how these populations are maintained 
remains enigmatic.
 
More than 100 years after the original
discovery of humoral immunity by Ki-
tasato and Behring in 1891 (1), we
have finally reached an understanding
of antibodies, which are the molecular
basis of humoral immunity. Under-
standing the cells that make these anti-
bodies, however, remains a challenge.
The work of Blink and collaborators in
this issue (2) provides evidence that in
systemic immune responses that are de-
pendent on help by T lymphocytes
both memory B cells and memory
plasma cells are generated in secondary
lymphoid organs; the two cell types
then exit these organs independently
and compete for survival niches with
preexisting memory cells. In the pri-
mary immune response of mice to the
experimental antigen 4(hydroxy-3)-
nitrophenyl, coupled to keyhole limpet
hemocyanin (NP-KLH), both memory
B cells and antibody-secreting cells with
specificity for the antigen appear in the
blood within 1 week after immunization.
This is surprisingly early, and as fast as in
secondary immune reactions in humans.
Odendahl and collaborators have recently
shown the appearance of a wave of anti-
body-secreting cells on days 6 and 7 af-
ter secondary immunization of hu-
mans with tetanus antigen, whereas
antigen-binding memory B cells ap-
peared only from day 8 onwards and
remained constant in numbers at least
until day 34 (3). The classification of
cells in the present study by Blink et al.
(2) is based on several surrogate markers
of B cell differentiation (B220, PNA-
binding, CD38, and CD138), the ex-
pression of surface antibodies that bind
antigen versus the secretion of antigen-
specific antibodies, and expression of
the transcription factor Blimp-1, a
hallmark of plasma cell differentiation.
Both memory B cells and memory
plasma cells express affinity-matured,
class-switched antibodies, and thus are
probably the output of germinal center
reactions, although recent work suggests
that somatic mutation can also occur in
B cells activated outside of germinal
centers (4, 5).
 
Selection of memory B cells
 
Blink et al. (2) showed that although
the numbers of circulating memory B
cells remained constant from early on in
the immune response, the affinity of
their antibodies increased. Also, the cir-
culating antigen-specific B cells were
attracted by the chemokine CXCL13, a
ligand of CXCR5, which allows cells to
navigate back into the secondary lym-
phoid organs. Surprisingly, interruption
of the immune response on day 7 by
ablation of T cell help eliminated at
least 50% of the circulating antigen-
binding B cells with memory pheno-
type, and there is no evidence that the
other 50% are really long-lived. This
raises the question whether the antigen-
specific B cells circulating early in the
response are bona fide memory B cells.
With respect to CD38 and PNA stain-
ing, they have a memory phenotype,
but their lifespan in the absence of
restimulation is rather limited. Appar-
ently, recruitment of circulating B cells
to the memory pool requires additional
instruction. Alternatively, circulating B
cells might only become memory B
cells if they find appropriate survival
conditions outside of restimulating sec-
ondary lymphoid organs. Thus, similar
to plasma cells, there might be short-
and long-lived memory B cells likely
determined by their affinity for the re-
spective antigen and their survival po-
tency, which is determined by the ex-
pression of genes that mediate survival
signals and prevent apoptosis (Fig. 1).
Inside and outside of “niches” provid-
ing the essential survival signals, the
phenotype of such B cells may be the
same, but their functions and lifespan
could be very different.
Although it is not clear whether re-
circulating antigen-binding B cells are
true memory B cells, in any case these
cells do not have an impressive potential
to develop into antibody-secreting cells
upon adoptive transfer in the absence of
antigen. Blink et al. (2) performed this
experiment on day 14 of the primary
immune response, and confirmed that
there are essentially no cells circulating
in blood that can develop into antibody-
secreting cells within 4 days in the
spleen or bone marrow in the absence
of antigen. It remains unclear whether
the few antibody-secreting cells (
 
 
 
100)
detected in spleen and bone marrow after
transfer of 10
 
7
 
 blood leukocytes have
been derived from the transferred mem-
ory B cells or from antibody-secreting
cells. Although the authors do not explic-
itly comment on it, the 75 antibody-
secreting  cells recovered 4 days after
transfer of cells from spleen and bone
marrow nicely correspond to the 50–75
antibody-secreting cells contained in
the 10
 
7
 
 blood leukocytes transferred on
day 14 after immunization, as can be es-
timated from the data in Fig. 5 of the
paper (2). Unfortunately, the adoptive
transfer of antibody-secreting cells from
blood has not been successful so far, so
it is difficult to confirm this assumption
directly.
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Selection of memory plasma cells
 
In the adoptive transfer experiments of
Blink et al. (2), it is remarkable that on
day 14 of a primary immune response
only 25 antibody-secreting cells can be
transferred with 10
 
7
 
 blood leukocytes to
the bone marrow of a recipient, whereas
25,000 antigen-specific antibody-secret-
ing cells are present in the bone marrow
of the donor at this time (again calculated
from Fig. 5, B and C [reference 2]).
When did these cells arrive in the bone
marrow from the blood? In human sec-
ondary immune reactions, a wave of spe-
cific antibody-secreting cells emerges in
blood on days 6–8, and very few are
found thereafter (3, 6). Admittedly, this
cannot directly be compared with pri-
mary murine immune responses, but the
question remains, how long would a
similar wave of antibody-secreting cells
be detectable in the small volume of mu-
rine blood? In the data shown in Fig. 5 A
of the paper (2), there is no difference
between day 0 and day 7 with respect to
the blood frequencies of CD138
 
 
 
 and
Blimp-1–expressing cells. One could ar-
gue that for primary immune responses
the wave of blood-antibody secreting
cells could be delayed or spread out over
a longer period of time. The present data
do not rule out this possibility, but
there was no indication of an increase
in blood-borne CD138
 
 
 
, Blimp-1–
expressing cells on day 9 either.
In the same analysis (2), blood taken
on day 7 of the mouse primary immune
response lacked not only a significant
population of antigen-specific antibody-
secreting cells, it also lacked a population
of cells expressing high levels of Blimp-1.
Such cells are found in spleen and bone
marrow on day 7, and they may rep-
resent more mature antibody-secret-
ing cells, probably plasma cells. In the
human secondary response to tetanus
vaccine, such cells are mobilized into the
blood and are characterized as cells ex-
pressing little MHC class II (3). Interest-
ingly, these human plasma cells are ap-
parently not specific for the vaccine.
Their numbers are increased markedly,
at the same time when vaccine-specific
antibody-secreting cells are found in the
blood. The latter express MHC class II
highly, a hallmark of plasmablasts, but
little CXCR3 and CXCR4. Neverthe-
less, these plasmablasts can migrate in
response to the corresponding chemo-
kines. Studies on the migration potential
of murine plasmablasts and plasma cells
suggest that by 12 days after their genera-
tion, in the course of their differentiation
from plasmablasts into plasma cells, anti-
body-secreting cells have switched their
response to CXCL12, the ligand of
CXCR4, from migration to survival (7).
This observation has prompted us to
speculate that plasmablasts, when com-
peting with resident plasma cells of the
bone marrow, may have a competitive
advantage, because once dislogded from
their survival niches plasma cells cannot
relocate efficiently (3). The lack of mi-
gration of plasma cells towards chemo-
attractants may also explain why adop-
tive transfers of bone marrow–resident
plasma cells poorly reconstitute the host
(8). In the murine primary immune re-
sponse, Blink et al. (2) found no evi-
dence for mobilization of resident plasma
cells from the bone marrow into the
blood, but the analysis does not focus on
whether plasmablasts of the primary im-
mune response compete with resident
plasma cells of the bone marrow for sur-
vival niches, and provides no clue on the
long-term stability of antigen-specific se-
rum antibody titers and numbers of anti-
body-secreting cells in the bone marrow.
Instead, the analysis focuses on the
question of whether there is an antigen-
binding immediate precursor of plasma
cells not expressing B220 in spleen or
bone marrow, as had been described
previously. Such cells should express
Blimp-1, since they have not been found
in 
 
Blimp-1
 
–deficient mice. Apart from
the question of whether such cells do
exist at all (9), they do definitely not ex-
ist in the primary immune response an-
alyzed here, among the cells binding
the antigen. It should be noted that in
previous experiments (10) adoptively
transferred, B220-negative bone mar-
row cells did not react to antigen by
differentiation into antibody-secreting
cells in a secondary murine immune re-
action either, leaving little room for
such memory cells in immunity.
 
Selection of high affinity
 
Affinity maturation is a hallmark of im-
munological memory, but how are cells
Figure 1. Hypothetical model for the generation of short- and long-lived memory B cells 
and antibody-secreting cells in primary immune reactions. Short- and long-lived memory B cells 
and plasma cells are the product of not only affinity maturation but also of an acquired ability to 
survive, which likely is related to successful competition for survival niches and factors.
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expressing antibodies of high affinity
for the antigen selectively recruited to
the memory compartment? In the pri-
mary immune response analyzed by
Blink et al. (2), B cells with memory
phenotype leave the secondary lym-
phoid organs for the blood 
 
 
 
2–3 days
after somatic hypermutation of their
antibody genes, that is, at any time
point of the immune reaction the mu-
tation frequency of blood B cells equals
that of splenic B cells 2–3 days previ-
ously. However, B cells expressing an-
tibodies with the high affinity muta-
tion 33Trp/Leu were released into the
blood as soon as they were generated.
Since the numbers of specific memory
B cells in blood remain constant over
the first 28 days of the immune reac-
tion, the increasing mutation frequency
in this population must be based on
turnover of the cells. This turnover
could be due to a limited lifespan of the
B cells released early on in the immune
response, or to recirculation of blood B
cells into the secondary lymphoid or-
gans and their further affinity matura-
tion there, as discussed by Blink et al.
(2). In conjunction with the preferen-
tial recruitment of B cells with high af-
finity antibodies to the blood, and irre-
spective of the underlying mechanism,
this turnover will result in a population
of the most affinity-matured blood-
borne antigen-specific B cells at the end
of the immune response. Whether all
or just some of these B cells are then
recruited to the compartment of long-
lived memory B cells remains to be
shown (Fig. 1).
The preferential recruitment of cells
secreting high affinity antibodies into
the bone marrow is another interest-
ing observation of Blink et al. (2).
Such cells probably can no longer sig-
nal through an antigen receptor, and
any selective advantage would have to
be implemented before their differenti-
ation into antibody-secreting cells. In-
deed, the affinity maturation observed
between day 7 and day 14 for cells
secreting specific antibodies, in bone
marrow and blood, could simply reflect
a lack of survival potency of antibody-
secreting cells generated in the early
phase of a primary immune response.
It will be interesting to learn whether
antibody-secreting cells of primary
immune responses have up-regulated
expression of antiapoptotic genes and
receptors for survival signals, such as
CXCR4 (7). One could imagine that
antibody-secreting cells will persist in
the bone marrow if they are generated
from memory B cells expressing high
affinity antibodies, and have already
been programmed for survival, for ex-
ample, by up-regulating antiapoptotic
genes. Such a mechanism would ensure
that protective humoral immunity by
serum antibodies is provided by plasma
cells secreting antibodies with an affin-
ity as high as the affinity of the anti-
bodies of the corresponding long-lived
memory B cell population, that is, the
reactive humoral memory. 
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